SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

Highlights Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Delayed NSE India S.E. Other stock markets 05:54:12 2024-04-30 am EDT			5-day change	1st Jan Change
232.3 ^INR	-4.99%		-22.61%	-19.00%

Apr. 15	Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Apr. 10	Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease	Apr. 09	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 05	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 06	CI
Sun Pharma Advanced Research Company Ltd. Completes Enrolment in Proosek, A Global Phase 2 Study of Vodobatinib in Early Parkinson's Disease	23-10-29	CI
Sun Pharma Advanced Research Company Limited Announces Incorporation of Wholly Owned Subsidiary Company	23-09-26	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-07	CI
Sun Pharma Advanced Research Company Limited Announces That FDA Issues Complete Response Letter for Pdp-716 Nda Due to Inspection Findings At Third-Party Api Manufacturing Facility	23-07-13	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-22	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Sun Pharma Advanced's Partner Launches Neonatal Seizure Drug SEZABY in US	23-01-25	MT
Sun Pharma Advanced, Sun Pharma Get US FDA Nod for Neonatal Seizures Treatment Drug	22-11-17	MT
Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Limited Announces U.S. FDA Approval of SEZABY (Phenobarbital Sodium Powder for Injection) for the Treatment of Neonatal Seizures	22-11-17	CI
Sun Pharma Unit and SPARC Sign Licensing Deal for Neonatal Seizure Drug in US	22-11-09	MT
Sun Pharma and Sun Pharma Advanced Research Company Ltd Sign Licensing Agreement	22-11-09	CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-07	CI
Sun Pharma Advanced Research : FY 2021-22	22-08-30	PU
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-08	CI
Sun Pharma Advanced Research Company Widens Net Loss in Fiscal Q4	22-05-17	MT
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-04	CI
Sun Pharma Advanced Research Company Limited to Present Updated Clinical Data of Vodobatinib (SCO-088) at the 63rd ASH Annual Meeting	21-12-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Highlights

Filters